ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/09/22 | 1,400 | 1,400 | 1,366 | 1,366 | -30 | -2.1% | 71,900 |
| 2017/09/21 | 1,408 | 1,408 | 1,388 | 1,396 | ±0 | ±0% | 58,300 |
| 2017/09/20 | 1,381 | 1,403 | 1,381 | 1,396 | -3 | -0.2% | 30,200 |
| 2017/09/19 | 1,365 | 1,400 | 1,365 | 1,399 | +31 | +2.3% | 67,900 |
| 2017/09/15 | 1,361 | 1,378 | 1,360 | 1,368 | -2 | -0.1% | 39,600 |
| 2017/09/14 | 1,389 | 1,396 | 1,367 | 1,370 | -19 | -1.4% | 48,800 |
| 2017/09/13 | 1,419 | 1,419 | 1,388 | 1,389 | -26 | -1.8% | 46,900 |
| 2017/09/12 | 1,390 | 1,415 | 1,385 | 1,415 | +37 | +2.7% | 57,500 |
| 2017/09/11 | 1,381 | 1,404 | 1,364 | 1,378 | +27 | +2% | 38,000 |
| 2017/09/08 | 1,399 | 1,400 | 1,345 | 1,351 | -31 | -2.2% | 98,600 |
| 2017/09/07 | 1,438 | 1,438 | 1,375 | 1,382 | -28 | -2% | 51,000 |
| 2017/09/06 | 1,360 | 1,422 | 1,359 | 1,410 | +32 | +2.3% | 82,700 |
| 2017/09/05 | 1,418 | 1,440 | 1,362 | 1,378 | -48 | -3.4% | 150,800 |
| 2017/09/04 | 1,466 | 1,468 | 1,409 | 1,426 | -63 | -4.2% | 174,100 |
| 2017/09/01 | 1,490 | 1,495 | 1,484 | 1,489 | +4 | +0.3% | 76,600 |
| 2017/08/31 | 1,480 | 1,499 | 1,476 | 1,485 | +15 | +1% | 120,900 |
| 2017/08/30 | 1,487 | 1,487 | 1,455 | 1,470 | +7 | +0.5% | 49,800 |
| 2017/08/29 | 1,450 | 1,463 | 1,448 | 1,463 | +8 | +0.5% | 37,300 |
| 2017/08/28 | 1,484 | 1,487 | 1,455 | 1,455 | -22 | -1.5% | 69,300 |
| 2017/08/25 | 1,480 | 1,483 | 1,463 | 1,477 | +45 | +3.1% | 156,400 |
| 2017/08/24 | 1,410 | 1,453 | 1,401 | 1,432 | +25 | +1.8% | 62,200 |
| 2017/08/23 | 1,393 | 1,421 | 1,393 | 1,407 | +12 | +0.9% | 38,600 |
| 2017/08/22 | 1,385 | 1,405 | 1,375 | 1,395 | +21 | +1.5% | 27,100 |
| 2017/08/21 | 1,392 | 1,395 | 1,368 | 1,374 | -35 | -2.5% | 64,200 |
| 2017/08/18 | 1,439 | 1,439 | 1,379 | 1,409 | -30 | -2.1% | 83,900 |
| 2017/08/17 | 1,411 | 1,439 | 1,408 | 1,439 | +19 | +1.3% | 56,700 |
| 2017/08/16 | 1,388 | 1,431 | 1,377 | 1,420 | +45 | +3.3% | 71,700 |
| 2017/08/15 | 1,366 | 1,385 | 1,354 | 1,375 | +12 | +0.9% | 63,200 |
| 2017/08/14 | 1,356 | 1,383 | 1,350 | 1,363 | -11 | -0.8% | 53,500 |
| 2017/08/10 | 1,396 | 1,401 | 1,352 | 1,374 | -22 | -1.6% | 100,500 |
| 2017/08/09 | 1,466 | 1,466 | 1,394 | 1,396 | -70 | -4.8% | 127,300 |
| 2017/08/08 | 1,461 | 1,495 | 1,433 | 1,466 | +5 | +0.3% | 93,000 |
| 2017/08/07 | 1,468 | 1,484 | 1,431 | 1,461 | -28 | -1.9% | 143,800 |
| 2017/08/04 | 1,360 | 1,489 | 1,360 | 1,489 | +116 | +8.4% | 252,700 |
| 2017/08/03 | 1,395 | 1,396 | 1,361 | 1,373 | -22 | -1.6% | 81,400 |
| 2017/08/02 | 1,381 | 1,420 | 1,380 | 1,395 | +10 | +0.7% | 73,100 |
| 2017/08/01 | 1,429 | 1,432 | 1,381 | 1,385 | -50 | -3.5% | 205,200 |
| 2017/07/31 | 1,451 | 1,455 | 1,430 | 1,435 | -16 | -1.1% | 85,500 |
| 2017/07/28 | 1,458 | 1,460 | 1,450 | 1,451 | ±0 | ±0% | 61,200 |
| 2017/07/27 | 1,479 | 1,482 | 1,451 | 1,451 | -23 | -1.6% | 141,700 |
| 2017/07/26 | 1,492 | 1,500 | 1,474 | 1,474 | -17 | -1.1% | 84,800 |
| 2017/07/25 | 1,490 | 1,500 | 1,486 | 1,491 | +1 | +0.1% | 49,100 |
| 2017/07/24 | 1,509 | 1,509 | 1,485 | 1,490 | -22 | -1.5% | 43,600 |
| 2017/07/21 | 1,513 | 1,517 | 1,500 | 1,512 | -1 | -0.1% | 45,300 |
| 2017/07/20 | 1,517 | 1,519 | 1,503 | 1,513 | +3 | +0.2% | 33,200 |
| 2017/07/19 | 1,485 | 1,510 | 1,484 | 1,510 | +29 | +2% | 40,500 |
| 2017/07/18 | 1,518 | 1,525 | 1,478 | 1,481 | -37 | -2.4% | 109,700 |
| 2017/07/14 | 1,528 | 1,532 | 1,518 | 1,518 | -6 | -0.4% | 37,000 |
| 2017/07/13 | 1,544 | 1,545 | 1,523 | 1,524 | -20 | -1.3% | 48,500 |
| 2017/07/12 | 1,536 | 1,551 | 1,534 | 1,544 | +9 | +0.6% | 46,600 |
1751～
1800
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
